Ruofei Li
Impact in
- Pharmacology top 10%
- Biological and pharmacological studies of plants
- Alkaloids: synthesis and pharmacology
-
- Traditional and Medicinal Uses of Annonaceae
Papers in
-
- Natural product bioactivities and synthesis 3
-
- Pharmacological Effects of Natural Compounds 3
- Alkaloids: synthesis and pharmacology 3
- Berberine and alkaloids research 2
- Co-authors
- Bao‐Song Cui (4 shared papers)Qi Hou (3 shared papers)Yirui Wang (1 shared paper)Jinye Bai (1 shared paper)Shuai Li (1 shared paper)Mingbao Lin (1 shared paper)Shuai Li (4 shared papers)Hua Sun (4 shared papers)
- Journals
- Journal of Asian Natural Products Research (2 papers)Journal of Ethnopharmacology (2 papers)Chinese Journal of Natural Medicines (2 papers)Journal of Proteome Research (1 paper)The EMBO Journal (1 paper)
- Partner nations
- ChinaUnited StatesGreece
In The Last Decade
Ruofei Li
23 papers receiving 307 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 38
- Pharmacology 62
- Biochemistry 24
- Hepatology 14
- Cancer Research 24
Countries citing papers authored by Ruofei Li
This map shows the geographic impact of Ruofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruofei Li more than expected).
Fields of papers citing papers by Ruofei Li
This network shows the impact of papers produced by Ruofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruofei Li. The network helps show where Ruofei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruofei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2019 | 34 | |
| 3 | 2020 | 30 | |
| 4 | 2019 | 26 | |
| 5 | 2023 | 23 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 14 | |
| 8 | 2024 | 13 | |
| 9 | 2019 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2023 | 7 | |
| 16 | 2023 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Ruofei Li
Ruofei Li is a scholar working on Molecular Biology, Pharmacology, Plant Science, Pharmacology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 309 indexed citations. Recurring topics across this work include Traditional and Medicinal Uses of Annonaceae (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Phytochemistry and Biological Activities (3 papers), Natural product bioactivities and synthesis (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Alkaloids: synthesis and pharmacology (3 papers), Berberine and alkaloids research (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmacology (38 citations), Pharmacology (62 citations), Biochemistry (24 citations), Hepatology (14 citations) and Cancer Research (24 citations). Ruofei Li has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Bao‐Song Cui, Qi Hou, Yirui Wang, Jinye Bai, Shuai Li, Mingbao Lin, Shuai Li, Hua Sun, Yong Xu and Chengbo Xu. Their work appears in journals such as Journal of Asian Natural Products Research, Journal of Ethnopharmacology, Chinese Journal of Natural Medicines, Journal of Proteome Research and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.